Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  dendritic cell-MART-1 peptide vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Gene Therapy and Vaccine Therapy after a Conditioning Regimen in Treating Patients with Stage IIIC-IV Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 08-02-020, NCI-2010-00229, 0802-901, 10-001212, 1600, 53.08.0-h, 53.0B.0·h, MART-1 F5 TCR, OB02·901, NCT00910650
Start Over